MSK House, London Road, Silk Willoughby, Sleaford NG34 8NY
Blogs
Browse every article from Lincolnshire Knee.
Recurrent patellar dislocation stems from structural defects — particularly abnormal trochlear groove shape, found in 68–85% of cases compared with 3–6% of the general population — that physiotherapy cannot correct.
Combining a collagen-scaffold injection with autologous stem cells outperformed stem-cell therapy alone in Grade IV knee osteoarthritis—where joint replacement is standard.
Robotic-assisted unicompartmental knee replacement produced 0% reinterventions over five years in a randomised trial, versus 9% for manual surgery—a precision-placement advantage that measurably reduces the need for revision.
An acellular collagen scaffold injected into focal knee cartilage defects recruits the patient's own progenitor cells; these cells progressively replace the collagen framework with native repair tissue, delivering a mean functional improvement of 30 points sustained at 12–36 months.
Midlife knee pain often comes from three common generators: degenerative meniscus tears, patellar tendinopathy and prepatellar or infrapatellar bursitis. Each has a distinct pattern of pain, swelling and trigger, and most cases start with conservative treatment, not scans or surgery.
Patellofemoral arthroplasty replaces only the kneecap joint, sparing healthy tibiofemoral cartilage; it reduces perioperative risk compared with total knee replacement but carries a durability trade-off, with ten-year survival around 85% versus 95%.
World-class orthopaedic surgeon
Consultant Cartilage Surgeon • Visiting Professor, University of Lincoln
Biology-led, faster return to activity.
Advanced OA injection for relief.
Keyhole cartilage regeneration.
“Regenerative science plus precise surgery and rehab can shorten recovery and protect long-term joint health.”
Ready to move again?
Self-referrals welcome. Insured and self-pay accepted.
